Evaluation of the National Environmental Health Plans (PNSE): focus on nanos

The High Council for Public Health (HCSP) published its Global Assessment of the National Health and Environment Plans (2004-2019) on Monday, June 20. Dated March 2022, it traces the evolution of public policies in health and environment in France over the last fifteen years and issues general and more specific recommendations. Those concerning the issue of manufactured nanomaterials – on which the HCSP heard AVICENN in May 2021 – are presented below.

Contributions of the PNSE to the consideration of nanomaterials

The HCSP concludes that the PNSE 2 and 3 have, in a global way, allowed to highlight the complex issue of nanomaterials, “poorly perceived by the public and little taken into account at the EU level in 2009, at the beginning of the NESP 2, especially in the regulatory field”. However, he considers that “the role of the NESPs to carry this theme is not clearly identified. (…) the process was initiated during the Grenelle Environment Forum and the national debate on nanotechnologies, which allowed it to be taken into account in the PNSE 2″..

Recommendations of the HCSP concerning nanos

Governance around nanos in France

The HCSP relays the calls from civil society (including AVICENN) to “more transversality between ministries to gain in efficiency”. It points out the situations of duplication between the action carried out at the national level within the framework of r-nano and the actions carried out in the regions (within the framework of PRSE) and calls for “create synergies and complements” between these two levels. The HCSP relays the remarks of AVICENN and the associations which “want more information, awareness and communication, but also sanctions from the public authorities when breaches are observed” and more transversality from the ministries that tend to act individually “in their organ pipe”, at the central level as well as at the deconcentrated level (in the DREETS or in the DREALs): “Each administration conducts its own inspection in companies, without sharing information or coordinating actions. A “nanos task force” should be set up to centralize information and work, also at the regional level.

r-nano register

The HSCP confirms that “the r-nano register must be improved because it is poorly filled out by industry and difficult to use because access is too restrictive. It should be opened up more widely and, in particular, to researchers working on the relationship between exposure and health effects in epidemiological studies“.
The HCSP is also in favor of increasing the resources dedicated to r-nano:“The Anses has only one person to manage the R-Nano registry, respond to requests from registrants, accompany them and produce the annual report, which is notoriously insufficient to steer and lead the action.

EpiNano device

The HCSP also advocates the removal of the difficulties faced by the EpiNano epidemiology device monitoring of the health of workers exposed to nanomaterialsvia “texts, and a decree or a circular” aimed at making the system binding (since the voluntary nature on which it is based has not allowed a sufficient number of companies and workers to be included).

Research on the risks associated with nanomaterials

The HCSP recommends supporting research aimed at better understanding the health impacts of exposure to nanomaterials.

It also asks that in the assessment of health risks of new technologies, the “balance between the risks and their socio-economic utility” be taken into account.

Finally, he would like to see a “safe(r) by design” approach that looks at all the risks and must be carried out before innovations are put on the market.

Public Information

Noting with AVICENN the weakness of the PNSE 4 concerning the stakes of information and awareness on nanomaterials, the HCSP recommends to“improve public information on the presence of nanomaterials in consumer products through clear labeling (“composcore” according to the HCSP opinion of 08/27/2020 or “toxiscore”) and enforce strict compliance with regulations”.

It remains to be seen how these recommendations will be taken into account to optimize the implementation of the PNSE 4.